- Home
- CIVI vs SRRK Comparison
CIVI vs SRRK Comparison
Compare CIVI & SRRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CIVI
- SRRK
- Stock Information
- Founded
- CIVI 1999
- SRRK 2012
- Country
- CIVI United States
- SRRK United States
- Employees
- CIVI N/A
- SRRK N/A
- Industry
- CIVI Oil & Gas Production
- SRRK Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CIVI Energy
- SRRK Health Care
- Exchange
- CIVI Nasdaq
- SRRK Nasdaq
- Market Cap
- CIVI 2.5B
- SRRK 3.2B
- IPO Year
- CIVI 2011
- SRRK 2018
- Fundamental
- Price
- CIVI $31.40
- SRRK $35.27
- Analyst Decision
- CIVI Buy
- SRRK Strong Buy
- Analyst Count
- CIVI 12
- SRRK 6
- Target Price
- CIVI $46.60
- SRRK $42.17
- AVG Volume (30 Days)
- CIVI 2.7M
- SRRK 1.3M
- Earning Date
- CIVI 07-31-2025
- SRRK 08-07-2025
- Dividend Yield
- CIVI 9.49%
- SRRK N/A
- EPS Growth
- CIVI 5.61
- SRRK N/A
- EPS
- CIVI 8.73
- SRRK N/A
- Revenue
- CIVI $5,071,808,000.00
- SRRK N/A
- Revenue This Year
- CIVI N/A
- SRRK N/A
- Revenue Next Year
- CIVI N/A
- SRRK $502.60
- P/E Ratio
- CIVI $3.65
- SRRK N/A
- Revenue Growth
- CIVI 22.15
- SRRK N/A
- 52 Week Low
- CIVI $22.79
- SRRK $6.76
- 52 Week High
- CIVI $74.04
- SRRK $46.98
- Technical
- Relative Strength Index (RSI)
- CIVI 57.37
- SRRK 55.02
- Support Level
- CIVI $28.53
- SRRK $33.60
- Resistance Level
- CIVI $32.16
- SRRK $35.90
- Average True Range (ATR)
- CIVI 1.41
- SRRK 2.09
- MACD
- CIVI 0.11
- SRRK -0.04
- Stochastic Oscillator
- CIVI 67.46
- SRRK 67.85
About CIVI Civitas Resources Inc.
Civitas Resources Inc is an independent exploration and production company engaged in the acquisition, development, and production of oil and associated liquids-rich natural gas in the Rocky Mountain region, in the Denver-Julesburg Basin of Colorado - DJ Basin. The company's operations are focused on developing the horizontal Niobrara and Codell formations that have a low-cost structure, mature infrastructure, production efficiencies, multiple producing horizons, multiple service providers, established reserves, and prospective drilling opportunities.
About SRRK Scholar Rock Holding Corporation
Scholar Rock Holding Corp is a late-stage biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for treating serious diseases in which signaling by protein growth factors plays a fundamental role. Its pipeline includes Neuromuscular and Obesity, Immuno-oncology, Fibrotic Disease, and Hematology. The group operates and manages its business as a single segment to assess performance and make operating decisions.